Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance

被引:34
作者
Greenwald, MK [1 ]
Johanson, CE [1 ]
Schuster, CR [1 ]
机构
[1] Wayne State Univ, Res Div Subst Abuse, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA
关键词
heroin dependence; opioids; buprenorphine; hydromorphone; reinforcement;
D O I
10.1016/S0376-8716(99)00032-0
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This study examined the reinforcing effects of hydromorphone (HYD) (0, 4, 8, and 16 mg/70 kg i.m.) in heroin-dependent outpatient volunteers maintained on buprenorphine (BUP) at doses of 2, 4, and 8 mg, each for 2 weeks. Following a week of maintenance at each dose, volunteers received injections of one of the four HYD doses under double-blind conditions. Eight volunteers (abstainers) were heroin-free during HYD test weeks, whereas six volunteers remained heroin-positive (nonabstainers). Among abstainers, HYD had minimal reinforcing value, whereas in nonabstainers there were marked dose-related increases in HYD reinforcing value, which were not attenuated by increasing doses of BUP. A similar pattern was found for HYD subjective agonist effects. Heroin craving among nonabstainers was significantly higher compared with abstainers, and was reduced in a dose-related manner by HYD. Although BUP and HYD produced dose-related miosis, abstinence status had no differential effect. In summary, BUP effects on opioid reinforcement were consistent from outpatient setting (heroin abstinence) to laboratory setting (decreased HYD reinforcement), supporting the validity of this laboratory model. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:191 / 203
页数:13
相关论文
共 29 条
[1]  
[Anonymous], [No title captured]
[2]   Buprenorphine Treatment of Opioid Dependence: A Review [J].
Bickel, Warren K. ;
Amass, Leslie .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1995, 3 (04) :477-489
[3]  
BICKEL WK, 1988, J PHARMACOL EXP THER, V247, P47
[4]  
BIGELOW GE, 1995, NIDA RES MONOGR, V153, P354
[5]   AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT [J].
COWAN, A ;
LEWIS, JW ;
MACFARLANE, IR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :537-545
[6]  
First M. B., 2016, USERS GUIDE SCID 5 1
[7]   Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers [J].
Fischman, MW ;
Johanson, CE .
BEHAVIOURAL PHARMACOLOGY, 1998, 9 (07) :479-498
[8]  
GREENWALD MK, 1999, PROBLEMS DRUG DEPEND
[9]  
GRIFFITHS RR, 1979, CLIN PHARMACOL THER, V25, P611
[10]  
GRIFFITHS RR, 1993, BEHAV PHARMACOL, V4, P3